Europe’s biotech industry recently celebrated its growth and progress with more than 120 events taking place across 18 European countries September 24 –30, in what organizers call “European Biotech Week.”
But during a roundtable discussion held in Brussels, the planned discussion topic, biotech’s contribution toward the United Nations’ third Sustainable Development Goal, “Ensure healthy lives and promote well-being for all at all ages,” was overshadowed, according to European news website Euractiv, by worries expressed by stakeholders that the continent’s biopharma industry is less attractive to investors than the world’s largest biopharma industry in the United States, and the fast-growing biopharma industry that has taken shape in China.
Image: https://www.genengnews.com
